Navigation Links
Recovery Resources Collaborates with Two Nonprofit Agencies for Children of Alcoholics Outreach Program
Date:9/7/2007

CLEVELAND, Sept. 7 /PRNewswire/ -- Three local nonprofit alcohol and drug treatment agencies have formed a collaborative to focus on the problems faced by the children of alcoholics and other drug addicts. Recovery Resources, Stella Maris and Community Challenge have banded together to produce a public awareness campaign, provide training for counselors and stage educational community forums. The initiative is being funded through a $145,000 grant from the St. Luke's Foundation of Cleveland.

"The Children of Alcoholics Outreach Program will be the first major effort in Greater Cleveland to raise awareness of the problems faced by the children of alcoholics and other drug addicts and to help them," stated Recovery Resources president and chief executive officer Helen K. Jones. "Our collaboration with Stella Maris and Community Challenge and the generosity of the St. Luke's Foundation will make it possible for us to inform the public, train the professionals and help those who seek assistance."

Recovery Resources will lead the public awareness campaign and manage the overall initiative; Stella Maris will provide clinical training to certified counselors and other licensed professionals; and Community Challenge will conduct community forums. Cleveland-based Adcom Communications has been selected to help develop and produce the public awareness campaign that will target the children of alcoholics as well as their families, friends and others who are concerned for them.

The first community forum will be held on Tuesday, September 11, 2007 from 7:00 p.m. to 8:30 p.m. at Lutheran Hospital Castele Learning Center, 1730 West 25 Street, Cleveland, Ohio 44113. Dr. Robert L. Smith, Ph.D. will conduct a workshop on "Help and Hope for Children of Alcoholics." The workshop is free and open to the public.

The grant for the Children of Alcoholics Outreach Program is one of ten grants totaling $1.4 million awarded by the St. Luke's Foundation of Clevela
'/>"/>

SOURCE Recovery Resources
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Amphetamines Help Recovery of Stroke Patients
2. Thyroid hormone treatment hastens recovery after cardiac surgery
3. Frozen Canadian baby stages miraculous recovery
4. New point scale to ascertain the stroke recovery
5. Combination Therapy Found To Improves Stroke Recovery
6. New Drug, Pleconaril speeds recovery from common cold
7. Recovery from lung injury
8. A new recovery for heart attacks
9. Recovery After Heart Transplantation
10. Use of Statin can help in recovery from stroke
11. Making operation and recovery time shorter

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)... Tarkett Sports, the worldwide leader in sports s...ct offering with a more complete and innovative ra...or sports flooring experts and the launch of www.... (PRWEB) November 9, 2009 -- Tarkett Sports, red...ing products includes hardwood and synthetic baske...
(Date:11/9/2009)...ness Month Highlighted During Broadcast ,, WAS...ncer Alliance (LCA) announced that LCA staff, advo...he New York Stock Exchange(TM) (NYSE) tomorrow aft...scom.com/cgi-bin/prnh/20081016/LCALOGO ) ,, Fi... advocate, Richard Heimler will mark the end of th...
(Date:11/9/2009)..., Nov. 9 Sutter Health, a family o...th care service providers, is donating $255,000 to...of local food banks will share the quarter-million...the tables of thousands of families across the nor... of partnering with and supporting charitable prog...
(Date:11/9/2009)...s President Obama,s promise to not expand abortion...Bishops still concerned for poor, elderly ,, W...nal Francis George of Chicago, president of the Un... the November 7 decision of the U.S. House of Repr...ney from paying for elective abortions. ,, In ...
(Date:11/9/2009)...l enlargement, study finds , , MONDAY, N...factor for left atrial enlargement, which increase...h, a new study shows. , Atrial fibrillation is ...eart rhythm or heartbeat). , Researchers analy... Germany who were followed for 10 years. The study...
Breaking Medicine News(10 mins):Health News:Tarkett Sports Launches Revamped Indoor Sports Flooring Division and New Indoor Website 2Health News:Lung Cancer Alliance Staff and Advocates to Ring Closing Bell of New York Stock Exchange(TM) 2Health News:Sutter Health Donates $255,000 to Help the Hungry This Holiday Season 2Health News:Cardinal George Lauds House Action to Ban Federal Funds for Abortion; Promises Vigilance as Senate Pursues Health Care Reform, Wary About Affect on Poor, Elderly 2Health News:Cardinal George Lauds House Action to Ban Federal Funds for Abortion; Promises Vigilance as Senate Pursues Health Care Reform, Wary About Affect on Poor, Elderly 3
...is growing day by day, the New South Wales (NSW) G...uce the queue//. It has decided to allocate to...This step is thought to help cut elective surgery ...go about the attending patients in a smoother mann...
...pted that periodontal disease is not a desirable c...babies, but for the first time researchers from Ca...edicine and the Department of Obstetrics and Gynec...ted Bergeyella Strain from the Oral Cavity to the ...
...ss of the Perinatal Society of Australia & New Zea...babies born prematurely at 23 weeks should be allo... or later must be committed to intensive care.// ...ts that developed the recommendations, said that t...
...rnia finds that vitamin D can have a hand in cance... lots of vitamin D are 50 per cent less likely to ... field read between the lines and hope it could al...akes the vitamin from sunlight, but experts sugges...
...entists of Kaiser Permanente, overweight or obesit...eloping Alzheimer’s disease// later in life. '...y of Neurology’s 58th Annual Meeting in San Diego.... The study participants were evaluated for ov...
... Engineering plans to unveil a reactor with a capa...y that would help// to meet India’s growing demand...of the bio-diesel research department in the colle...partment of mechanical engineering, said his 10-me...
Other Medicine News:Health News:Fuel demand to be met by Bio-diesel 2
(Date:11/9/2009)...wire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Na... the third quarter ended September 30, 2009. ,,...on stockholders in the third quarter of 2009 of $3... loss allocable to common stockholders in the thir...hare, and a net loss allocable to common stockhold...
(Date:11/9/2009)...re/ -- Groundbreaking articles in current issues o...time explore, in depth, the emergence of cannabino...ers and its potential benefits for patients. ,,...gton authors, Sunil Aggarwal, PhD who is a member ...ram and who conducted the article,s research and G...
(Date:11/9/2009)...re/ -- Celling Technologies, a subsidiary of Spine...is, Inc. to research potential applications for ad... acquired the global rights in spine for Tissue Ge...nology in November of 2007. Replacing the prior a...lling Technologies to further research adipose tis...
Breaking Medicine Technology:Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 2Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 3Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 4Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 5Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 6Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 7Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 8Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 9Medicinal Use of Marijuana: Past, Present and Future...A Fresh Look by Experts in the Field 2Celling Technologies Signs Exclusive Agreement to Research and Develop Adipose Tissue Stem Cell Technology in Regenerative Medicine Institutes 2Celling Technologies Signs Exclusive Agreement to Research and Develop Adipose Tissue Stem Cell Technology in Regenerative Medicine Institutes 3HHS Awards MedImmune Contract to Manufacture Live Attenuated Nasal Spray Vaccine for Novel Influenza A 28H1N1 29 12381 1HHS Awards MedImmune Contract to Manufacture Live Attenuated Nasal Spray Vaccine for Novel Influenza A 28H1N1 29 12381 2HHS Awards MedImmune Contract to Manufacture Live Attenuated Nasal Spray Vaccine for Novel Influenza A 28H1N1 29 12381 3HHS Awards MedImmune Contract to Manufacture Live Attenuated Nasal Spray Vaccine for Novel Influenza A 28H1N1 29 12381 4Proteolix Presents Positive Clinical Data for Carfilzomib in Multiple Myeloma at the 2009 ASCO Annual Meeting 4502 1Proteolix Presents Positive Clinical Data for Carfilzomib in Multiple Myeloma at the 2009 ASCO Annual Meeting 4502 2Proteolix Presents Positive Clinical Data for Carfilzomib in Multiple Myeloma at the 2009 ASCO Annual Meeting 4502 3Proteolix Presents Positive Clinical Data for Carfilzomib in Multiple Myeloma at the 2009 ASCO Annual Meeting 4502 4Proteolix Presents Positive Clinical Data for Carfilzomib in Multiple Myeloma at the 2009 ASCO Annual Meeting 4502 5Proteolix Presents Positive Clinical Data for Carfilzomib in Multiple Myeloma at the 2009 ASCO Annual Meeting 4502 6Keryx Biopharmaceuticals Announces Positive Data from a Randomized Multi Center Placebo Controlled Phase 2 Combination Study of KRX 0401 28Perifos 4500 1Keryx Biopharmaceuticals Announces Positive Data from a Randomized Multi Center Placebo Controlled Phase 2 Combination Study of KRX 0401 28Perifos 4500 2Keryx Biopharmaceuticals Announces Positive Data from a Randomized Multi Center Placebo Controlled Phase 2 Combination Study of KRX 0401 28Perifos 4500 3Keryx Biopharmaceuticals Announces Positive Data from a Randomized Multi Center Placebo Controlled Phase 2 Combination Study of KRX 0401 28Perifos 4500 4Keryx Biopharmaceuticals Announces Positive Data from a Randomized Multi Center Placebo Controlled Phase 2 Combination Study of KRX 0401 28Perifos 4500 5Keryx Biopharmaceuticals Announces Positive Data from a Randomized Multi Center Placebo Controlled Phase 2 Combination Study of KRX 0401 28Perifos 4500 6
...sdaq: TELK ) reported positive preclinical data f...ecule inhibitors of validated cancer targets,inclu...ented today at the,AACR-NCI-EORTC Conference on Mo...ncisco. Aurora kinases are enzymes that play a ke...-expressed in many human cancers, including breast...
...., a,privately held biopharmaceutical company deve...cular biomarker data demonstrating the overexpress...in in multiple cancers,including ovarian, breast a...ation of PARP overexpression in specific types of ...inical development of the company,s,pipeline of PA...
Other Medicine Technology:Telik Announces Preclinical Data Demonstrating Anti-Cancer Activity of Dual Inhibitors of Aurora Kinase and VEGFR2 2BiPar Genomic Biomarker Data Demonstrate Overexpression of PARP-1 Gene in Multiple Cancer Types 2
Neuro-Cool™ Cool Head Wrap
...noWELL Mycoplasma Pneumoniae Antibody (IgG) Test i...the detection of clinically significant IgG antibo...nt human serum specimens. The test should not be u...ycoplasma Pneumoniae Antibody (IgM) Test and is no...
ImmunoDOT Mono M Test
...noWELL VCA IgG Test is an ELISA method for the qua... Virus viral capsid antigen (VCA) in human serum. ...other testing such as the EBV nuclear antigen (EBN...heterophile tests, the results can serve as an aid...
Medicine Products: